BNF for Children (BNFC) 2018-2019

▶Child 12–17 years: 100 micrograms daily, increased if

necessary up to 200 micrograms daily, dose to be

sprayed into each nostril; reduced to 50 micrograms

daily, dose to be reduced when control achieved, dose

to be sprayed into each nostril

lINTERACTIONS→Appendix 1 : corticosteroids

lSIDE-EFFECTS

SIDE-EFFECTS, FURTHER INFORMATIONNasal ulceration

occurs commonly with preparations containing

mometasone furoate.

lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Spray
EXCIPIENTS:May contain Benzalkonium chloride, polysorbates
▶Mometasone furoate (Non-proprietary)
Mometasone furoate 50 microgram per 1 doseMometasone
50 micrograms/dose nasal spray| 140 doseP£ 7. 30 DT = £ 1. 70
▶Nasonex(Merck Sharp & Dohme Ltd)
Mometasone furoate 50 microgram per 1 doseNasonex
50 micrograms/dose nasal spray| 140 doseP£ 7. 68 DT = £ 1. 70

eiiiiF 698

Triamcinolone acetonide 21-Dec-2017

lINDICATIONS AND DOSE

Prophylaxis and treatment of allergic rhinitis

▶BY INTRANASAL ADMINISTRATION

▶Child 2–5 years: 55 micrograms once daily for maximum

3 months, dose to be sprayed into each nostril

▶Child 6–11 years: 55 micrograms once daily, dose to be

sprayed into each nostril, increased if necessary to

110 micrograms once daily, dose to be sprayed into

each nostril; reduced to 55 micrograms once daily, dose

to be sprayed into each nostril, reduce dose when

control achieved; maximum duration of treatment

3 months

▶Child 12–17 years: 110 micrograms once daily, dose to be

sprayed into each nostril, reduced to 55 micrograms

once daily, dose to be sprayed into each nostril, reduce

dose when control achieved

lUNLICENSED USENot licensed for use in children under
6 years.

lINTERACTIONS→Appendix 1 : corticosteroids

lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Spray
EXCIPIENTS:May contain Benzalkonium chloride, disodium edetate,
polysorbates
▶Nasacort(Sanofi)
Triamcinolone acetonide 55 microgram per 1 doseNasacort
Allergy 55 micrograms/dose nasal spray| 30 dosep£ 3. 01
Nasacort 55 micrograms/dose nasal spray| 120 doseP£ 7. 39 DT =
£ 7. 39

MAST-CELL STABILISERS

Sodium cromoglicate

(Sodium cromoglycate)

lINDICATIONS AND DOSE

Prophylaxis of allergic rhinitis

▶BY INTRANASAL ADMINISTRATION

▶Child: 1 spray 2 – 4 times a day, to be administered into

each nostril

lUNLICENSED USELicensed for use in children (age range
not specified by manufacturers).

lSIDE-EFFECTS

▶Rare or very rareBronchospasm (transient)

▶Frequency not knownLocal reaction

lMEDICINAL FORMS

No licensed medicines listed.

Oropharynx

1 Dry mouth

Treatment of dry mouth

Overview

Dry mouth (xerostomia) may be caused by drugs with

antimuscarinic (anticholinergic) side-effects (e.g.

antispasmodics and sedating antihistamines), by irradiation

of the head and neck region or by damage to or disease of the

salivary glands. Children with a persistently dry mouth may

develop a burning or scalded sensation and have poor oral

hygiene; they may develop dental caries, periodontal

disease, and oral infections (particularly candidiasis). Dry

mouth may be relieved in many patients by simple measures

such as frequent sips of cool drinks or sucking pieces of ice or

sugar-free fruit pastilles. Sugar-free chewing gum stimulates

salivation in patients with residual salivary function.

Artificial salivacan provide useful relief of dry mouth. A

properly balanced artificial saliva should be of a neutral pH

and contain electrolytes (includingfluoride) to correspond

approximately to the composition of saliva. The acidic pH of

some artificial saliva products may be inappropriate.

Artificial saliva products

lARTIFICIAL SALIVA PRODUCTS

AS SALIVA ORTHANA®LOZENGES

Mucin 65 mg, xylitol 59 mg, in a sorbitol basis, pH neutral

lINDICATIONS AND DOSE

Dry mouth as a result of having (or having undergone)

radiotherapy (ACBS)|Dry mouth as a result of sicca

syndrome (ACBS)

▶BY MOUTH

▶Child: 1 lozenge as required, allow to dissolve slowly in

the mouth

lPRESCRIBING AND DISPENSING INFORMATIONAS Saliva

Orthana®lozenges do not containfluoride.

AS Saliva Orthana lozenges(A S Pharma Ltd)

30 lozenge(ACBS).NHS indicative price = £ 3. 50 .Drug Tariff (Part VIIIA

Category C) price = £ 3. 50

AS SALIVA ORTHANA®SPRAY

Gastric mucin (porcine) 3. 5 %, xylitol 2 %, sodiumfluoride

4. 2 mg/litre, with preservatives andflavouring agents, pH

neutral.

lINDICATIONS AND DOSE

Symptomatic treatment of dry mouth

▶BY MOUTH

▶Child:Apply 2 – 3 sprays as required, spray onto oral

and pharyngeal mucosa

lPROFESSION SPECIFIC INFORMATION

Dental practitioners’formulary

AS Saliva Orthana®Oral Spray may be prescribed.

BNFC 2018 – 2019 Dry mouth 701

Ear, nose and oropharynx

12